<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cyclic <z:chebi fb="0" ids="16750">guanosine</z:chebi> monophosphate (cGMP) and its primary signaling kinase, protein kinase G, play an important role in counterbalancing stress remodeling in the heart </plain></SENT>
<SENT sid="1" pm="."><plain>Growing evidence supports a positive impact on a variety of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> conditions from the suppression of cGMP hydrolysis </plain></SENT>
<SENT sid="2" pm="."><plain>The latter is regulated by members of the phosphodiesterase (PDE) superfamily, of which cGMP-selective PDE5 has been best studied </plain></SENT>
<SENT sid="3" pm="."><plain>Inhibitors such as sildenafil and tadalafil ameliorate cardiac pressure and volume overload, ischemic injury, and cardiotoxicity </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical trials have begun exploring their potential to benefit <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> with a preserved ejection fraction </plain></SENT>
<SENT sid="5" pm="."><plain>This review discusses recent developments in the field, highlighting basic science and clinical studies </plain></SENT>
</text></document>